Q4 2024 Earnings Call Transcript February 11, 2025 Arvinas, Inc. beats earnings expectations. Reported EPS is $-0.63, ...
Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...
New packaging solution ensures all take-home products are recyclable through most curb-side programsBELVIDERE, NJ, Feb. 13, ...
Genprex’s (GNPX) research collaborators at a major cancer research center in Houston, Texas have published a new study which used the company’s ...
According to a recent study, Taiwanese researchers found that DUSP2 gene deficiency aids cancer cell growth, especially in ...
In a pioneering collaboration with AbbVie, Northwestern researchers have discovered a new way to potentially treat cancer by ...
The research uncovers key genetic mutations that affect cancer treatment responses and develops a predictive tool for ...
A groundbreaking study has uncovered how specific genetic mutations influence cancer treatment outcomes -- insights that could help doctors tailor treatments more effectively. The largest study of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results